Free Trial
NYSE:CVS

CVS Health (CVS) Stock Price, News & Analysis

$56.90
+0.28 (+0.49%)
(As of 07/8/2024 ET)
Today's Range
$56.62
$57.38
50-Day Range
$53.63
$67.73
52-Week Range
$52.77
$83.25
Volume
5.91 million shs
Average Volume
9.54 million shs
Market Capitalization
$71.43 billion
P/E Ratio
10.00
Dividend Yield
4.67%
Price Target
$75.05

CVS Health MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.57 Rating Score
Upside/​Downside
31.9% Upside
$75.05 Price Target
Short Interest
Healthy
1.65% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-1.25
Upright™ Environmental Score
News Sentiment
0.49mentions of CVS Health in the last 14 days
Based on 14 Articles This Week
Insider Trading
Acquiring Shares
$53,880 Bought Last Quarter
Proj. Earnings Growth
10.54%
From $7.02 to $7.76 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

5.00 out of 5 stars

Retail/Wholesale Sector

1st out of 184 stocks

Drug Stores & Proprietary Stores Industry

1st out of 3 stocks

CVS stock logo

About CVS Health Stock (NYSE:CVS)

CVS Health Corporation, founded in 1963 by Stanley Goldstein, Sidney Goldstein and Ralph Hoagland, began as Melville, a health and beauty aid store chain in Lowell, Massachusetts. 

In 1996, CVS Corporation spun off from Melville and became a standalone company trading as CVS on the New York Stock Exchange. Today, CVS Health Corporation is a leading American healthcare company that owns CVS Pharmacy, CVS Caremark and Aetna.

CVS Health Corp offers its customers a range of health solutions. It operates through three main segments: healthcare benefits, pharmacy services and retail. The Health Care Benefits segment provides various traditional, voluntary and consumer-directed health insurance products to different groups, including individuals, employer groups, college students, health care providers and governmental units. 

The pharmacy services segment offers a range of pharmacy benefit management solutions, including plan design and administration, clinical, formulary management, retail pharmacy network management, specialty pharmacy and infusion and medical spend management services. This segment serves insurance companies, prescription drug plans, health plans, unions, employers, Medicaid-managed care plans and individuals. 

The retail segment sells prescription and over-the-counter drugs, personal care products and consumer health and beauty products. It also provides health care services through MinuteClinic walk-in medical clinics. It distributes prescription drugs while offering pharmacy consulting and other ancillary services to care facilities and different care settings. Additionally, it operates specialty mail-order, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services.

CVS Health Corporation is one of the largest healthcare providers in the United States. In 2021, it ranked fourth on the Fortune 500 list and seventh on the Fortune Global 500 list. 

The company faced criticism in November 2021 when a federal jury found that CVS, Walgreens and Walmart "had substantially contributed to" the opioid crisis. Despite this setback, CVS Health Corp remains dedicated to its broader healthcare commitment, as reflected by its decision to change its corporate name to CVS Health in September 2014. In February 2020, CVS Health announced changes to its board of directors, reducing the size from 16 to 13 directors.

In December 2017, CVS Health Corp agreed to acquire Aetna for $69 billion, completing the acquisition in November 2018. The purchase of Aetna, a leading health insurance company, allowed CVS Health Corp to expand its services to a broader range of customers. 

CVS Health Corp's success is also due to its subsidiary, Caremark, established in 1979 by James M. Sweeney as Home Health Care of America (HHCA), which later changed its name to Caremark in 1985. In 1996, Caremark merged with MedPartners/Mullikin Inc., the combined company called MedPartners Inc. In 1998, MedPartners changed its name to Caremark Rx. Caremark was fined $160 million in 1991 for a "four-year-long federal mail-fraud and kickback" scheme in which it "paid doctors to steer patients to its intravenous drug service."

On November 18, 2021, CVS Health announced plans to close 900 stores over the next three years, with closing beginning in the spring of 2022. The company's decision to close stores could result from increased competition in the healthcare industry, changing consumer behavior and the COVID-19 pandemic. The company is confident in its ability to continue to provide quality healthcare services to customers.

CVS Stock Price History

CVS Stock News Headlines

walgreens logo sign on storefront
What's Behind Walgreens Stock Plunge: What Investors Can Do Next
Shares of Walgreens are down over 25% in a single day, pushing investors to seek an answer. There is a lateral play that can be considered for income here
CVS Health Co. (NYSE:CVS) Declares Quarterly Dividend of $0.67
50-year Wall Street Legend: “Prepare for a cash avalanche”
The Dow crossed 40,000 for the first time in history… The S&P has hit over 30 all-time highs since the start of the year.
Here’s Why CVS Health Corporation (CVS) Slipped in Q2
CVS Health announces quarterly dividend
CVS Health: Good Buy Vs. Goodbye
Analysts Set CVS Health Co. (NYSE:CVS) Price Target at $75.05
50-year Wall Street Legend: “Prepare for a cash avalanche”
The Dow crossed 40,000 for the first time in history… The S&P has hit over 30 all-time highs since the start of the year.
Vltava Fund - CVS Health Corp.: Why We Sold CVS
Is CVS Health Stock a Buy?
CVS Health (NYSE:CVS) Shares Gap Down to $60.63
3 Beaten-Down Stocks Ready for a Comeback: June 2024
See More Headlines
Receive CVS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CVS Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 5/1 Dividend
4/19/2024
Last Earnings
5/01/2024
Dividend Payable
5/01/2024
Today
7/09/2024
Dividend Payable
8/01/2024
Next Earnings (Estimated)
8/07/2024
Fiscal Year End
12/31/2024
Ex-Dividend for 8/1 Dividend
1/01/2100

Industry, Sector and Symbol

Industry
Drug stores & proprietary stores
Sub-Industry
Drug Retail
CUSIP
12665010
Employees
300,000
Year Founded
1963

Price Target and Rating

Average Stock Price Target
$75.05
High Stock Price Target
$100.00
Low Stock Price Target
$58.00
Potential Upside/Downside
+31.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.57
Research Coverage
23 Analysts

Profitability

Net Income
$8.34 billion
Pretax Margin
2.74%

Debt

Sales & Book Value

Annual Sales
$357.78 billion
Cash Flow
$12.21 per share
Book Value
$59.55 per share

Miscellaneous

Outstanding Shares
1,255,370,000
Free Float
1,252,360,000
Market Cap
$71.43 billion
Optionable
Optionable
Beta
0.52

Social Links

7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Ms. Karen Sue LynchMs. Karen Sue Lynch (Age 61)
    President, CEO & Director
    Comp: $5.12M
  • Mr. Thomas Francis Cowhey (Age 52)
    Executive VP & CFO
    Comp: $1.83M
  • Mr. Tilak Mandadi (Age 59)
    Executive VP of Ventures and Chief Digital, Data, Analytics & Technology Officer
    Comp: $2.38M
  • Mr. Samrat S. Khichi Esq. (Age 57)
    Executive VP, Chief Policy Officer & General Counsel
    Comp: $3.39M
  • Mr. Prem S. Shah Pharm.D (Age 44)
    Executive VP, Chief Pharmacy Officer and President of Pharmacy & Consumer Wellness
    Comp: $2.58M
  • Mr. Vijay Patel
    Senior Director of Business Development & CVS Health and Partner & Co-Founder
  • Mr. James David ClarkMr. James David Clark (Age 59)
    Senior VP, Controller & Chief Accounting Officer
  • Mr. Laurence F. McGrath
    Senior Vice President of Business Development & Investor Relations
  • Mr. David A. Falkowski
    Executive VP & Chief Compliance Officer
  • Ms. Laurie P. Havanec (Age 63)
    Executive VP & Chief People Officer

Should I Buy CVS Health Stock? CVS Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in CVS Health Co.:

  • CVS Health Corporation provides health solutions in the United States, operating through various segments including Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness.
  • The company offers traditional, voluntary, and consumer-directed health insurance products, catering to a wide range of customers.

Cons

Investors should be bearish about investing in CVS Health Co. for these reasons:

  • Cervantes Corporation Limited, not related to CVS Health Co., engages in the exploration and evaluation of mineral resource projects in Australia, which may cause confusion for investors.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, June 24, 2024. Please send any questions or comments about these CVS Health pros and cons to contact@marketbeat.com.

CVS Stock Analysis - Frequently Asked Questions

How have CVS shares performed this year?

CVS Health's stock was trading at $78.96 at the beginning of the year. Since then, CVS stock has decreased by 27.9% and is now trading at $56.90.
View the best growth stocks for 2024 here
.

How were CVS Health's earnings last quarter?

CVS Health Co. (NYSE:CVS) announced its quarterly earnings data on Wednesday, May, 1st. The pharmacy operator reported $1.31 EPS for the quarter, missing the consensus estimate of $1.69 by $0.38. The firm's revenue was up 3.7% on a year-over-year basis.
Read the conference call transcript
.

What is Larry J. Merlo's approval rating as CVS Health's CEO?

6,978 employees have rated CVS Health Chief Executive Officer Larry J. Merlo on Glassdoor.com. Larry J. Merlo has an approval rating of 37% among the company's employees. This puts Larry J. Merlo in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Does CVS Health have any subsidiaries?

CVS Health subsidiaries include these companies: IlliniCare Health, EntrustRX, Aetna, TargetPharmacy, Omnicare, Navarro Discount Pharmacy, Coram Specialty Infusion, and more.

Who are CVS Health's major shareholders?

Top institutional shareholders of CVS Health include Douglas Lane & Associates LLC (0.09%), ST Germain D J Co. Inc. (0.02%), DNB Asset Management AS (0.02%) and Thompson Investment Management Inc. (0.01%). Insiders that own company stock include Thomas M Moriarty, Karen S Lynch, Alan Lotvin, Prem S Shah, Edward J Ludwig, James David Clark, Daniel P Finke, Jonathan C Roberts and Troyen A Brennan.
View institutional ownership trends
.

How do I buy shares of CVS Health?

Shares of CVS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of CVS Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that CVS Health investors own include AT&T (T), Walt Disney (DIS), Johnson & Johnson (JNJ), NVIDIA (NVDA), Cisco Systems (CSCO), AbbVie (ABBV) and Verizon Communications (VZ).

This page (NYSE:CVS) was last updated on 7/9/2024 by MarketBeat.com Staff

From Our Partners